Aubree, J. C. & Lader, M. (1980) High and very high dosage antipsychotics: a critical review. Journal of Clinical Psychiatry, 41, 341–350.
Canales, P. L., Olsen, J., Miller, A. L., et al (1999) Role of antipsychotic polypharmacotherapy in the treatment of schizophrenia. CNS Drugs, 12, 179–188.
Davidson, J. (1974) Possible effects of combining phenothiazines. American Journal of Psychiatry, 131, 1408–1409.
Glassman, A. H. & Bigger, J.T. (2001) Antipsychotic drugs: QTc interval, torsade de pointes, and sudden death. American Journal of Psychiatry, 158, 1774–1782.
Godleski, L. S., Kerler, R., Barber, J.W., et al (1989) Multiple versus single antipsychotic drug treatment in chronic psychosis. The Journal of Nervous and Mental Disease, 177, 686–689.
Harrington, M., Lelliott, P., Paton, C., et al (2002a) The results of a multi-centre audit of the prescribing of antipsychotic drugs for in-patients in the UK. Psychiatric Bulletin, 26, 414–418.
Harrington, M., Lelliott, P., Paton, C., et al (2002b) Variation between services in polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patients. Psychiatric Bulletin, 26, 418–420.
Kapur, S., Zipursky, R., Jones, C., et al (2000) Relationship between dopamine D2 occupancy, clinical response and side effects: a double-blind PET study of first-episode schizophrenia. American Journal of Psychiatry, 157, 514–519.
Lelliott, P., Paton, C., Harrington, M., et al (2002) The influence of patient variables in polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patients. Psychiatric Bulletin, 26, 411–414.
National Institute for Clinical Excellence (2002) Guidance on the Use of Newer (Atypical) Antipsychotic Drugs for the Treatment of Schizophrenia. . London: NICE.
Ray, W. A., Meredith, S., Thapa, P. B., et al (2001) Antipsychotics and the risk of sudden cardiac death. Archives of General Psychiatry, 58, 1161–1167.
Taylor, D., Holmes, R., Hilton, T., et al (1997) Evaluating and improving the quality of risperidone prescribing. Psychiatric Bulletin, 21, 680–683.
Taylor, D., Mace, S., Mir, S., et al (2000) A prescription survey of the use of atypical antipsychotics for hospital inpatients in the United Kingdom. International Journal of Psychiatry in Clinical Practice, 4, 41–46.
Taylor, D., Mir, S., Mace, S., et al (2002a) Co-prescribing of atypical and typical antipsychotics – prescribing sequence and documented outcome. Psychiatric Bulletin, 26, 170–172
Taylor, D., Young, C. & Paton, C. (2002b) Prior antipsychotic prescribing in patients currently receiving clozapine – a case note review. Journal of Clinical Psychiatry, .
Waddington, J. L., Youssef, H. A. & Kinsella, A. (1998) Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study. British Journal of Psychiatry, 173, 325–329.
Yuzda, M. S. K. (2000) Combination antipsychotics: What is the evidence?
The Journal of Informed Pharmacotherapy, 2, 300–305.